Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence s...

Por Cohen, Stanley, Genovese, Mark C, Choy, Ernest, Perez-Ruiz, Fernando, Matsumoto, Alan, Pavelka, Karel, Pablos, Jose L, Rizzo, Warren, Hrycaj, Pawel, Zhang, Nan, Shergy, William, Kaur, Primal
Publicado no Ann Rheum Dis (2017)

Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis

Por Westhovens, Rene, Robles, Manuel, Ximenes, Antonio Carlos, Wollenhaupt, Jurgen, Durez, Patrick, Gomez-Reino, Juan, Grassi, Walter, Haraoui, Boulos, Shergy, William, Park, Sung-Hwan, Genant, Harry, Peterfy, Charles, Becker, Jean-Claude, Murthy, Bindu
Publicado no Ann Rheum Dis (2015)

Assessing the Feasibility of The Effectiveness of DiscontinuinG bisphosphonatEs Trial: A Pilot Study

Por Wright, Nicole C., Foster, Phillip J., Mudano, Amy S., Melnick, Joshua A., Lewiecki, E. Michael, Shergy, William J., Curtis, Jeffrey R., Cutter, Garry R., Danila, Maria I., Kilgore, Meredith L., Lewis, C. Elizabeth, Morgan, Sarah L., Redden, David T., Warriner, Amy H., Saag, Kenneth G.
Publicado no Osteoporos Int (2017)